ZOMIG RAPIMELT
Identification of Zomig Rapimelt
| No description |
Google image searchProduct monograph
Active ingredient
zolmitriptan, 2.5 MG
DIN: 02243045
Dosage form(s): TABLET (ORALLY DISINTEGRATING)
Route(s) of administration: ORAL
Schedule: Prescription
Company: XEDITON PHARMACEUTICALS INC
Date: 12-JAN-2023
ATC:
- N02 — ANALGESICS (ATC, ATC/DDD, )
- N02C — ANTIMIGRAINE PREPARATIONS (ATC, ATC/DDD)
- N02CC — Selective serotonin (5HT1) agonists (ATC, ATC/DDD)
- N02CC03 — ZOLMITRIPTAN (ATC/DDD)
Reference brand drug: Zomig
Pharmaceutical standard: MFR
